2025-01-31T16:02:28-06:00 2023-12-31 362938874 OSTROW REISIN BERK & ABRAMS LTD 455 N CITYFRONT PLAZA DR SUITE 1600 CHICAGO IL 60611 990 2023-01-01 237067756 FOUNDATION FOR WOMEN'S CANCER FOUN 3122354060 620 N LA SALLE DR CHICAGO IL 60654 KIMBERLY HOARLE CEO 3122354060 2025-01-23 1 0 KENNETH L TORNHEIM P00079651 3126707444 2025-01-23 2023 2025-03-06 01:10:19Z X KIMBERLY HOARLE 620 N LA SALLE DR CHICAGO IL 60654 2506604 0 X WWW.FOUNDATIONFORWOMENSCANCER.ORG X 1998 IL TO IMPROVE THE CARE OF PATIENTS WITH GYNECOLOGIC CANCER; TO ADVANCE KNOWLEDGE AND RAISE STANDARDS OF PRACTICE IN GYNECOLOGIC ONCOLOGY WITHIN THE DISCIPLINE OF OBSTETRICS AND GYNECOLOGY; TO ENCOURAGE RESEARCH AND COOPERATION WITH OTHER INDIVIDUALS AND ORGANIZATIONS INTERESTED IN ONCOLOGY AND RELATED FIELDS. 16 16 0 50 0 0 2328546 1903051 18638 20540 6338 554955 1885 28058 2355407 2506604 551000 610000 0 0 0 0 0 0 69499 1262408 1439930 1813408 2049930 541999 456674 6720975 7344658 1172878 1156355 5548097 6188303 X TO IMPROVE THE CARE OF PATIENTS WITH GYNECOLOGIC CANCER; TO ADVANCE KNOWLEDGE AND RAISE STANDARDS OF PRACTICE IN GYNECOLOGIC ONCOLOGY WITHIN THE DISCIPLINE OF OBSTETRICS AND GYNECOLOGY; TO ENCOURAGE RESEARCH AND COOPERATION WITH OTHER INDIVIDUALS AND ORGANIZATIONS INTERESTED IN ONCOLOGY AND RELATED FIELDS. 0 0 947515 610000 THE FOUNDATION ISSUES RESEARCH GRANTS TO PROVIDE A LIAISON/FELLOW TO THE NATIONAL CANCER INSTITUTE AND OTHER CANCER-BASED HEALTH AND MEDICAL AGENCIES. THESE FUNDS ARE ALLOCATED TO PROMOTE AND INITIATE RESEARCH IN THE FIELD, PROVIDE GRANTS TO THE MEDICAL COMMUNITY FOR FURTHER RESEARCH, AND REPORT FINDINGS RELATED TO GYNECOLOGIC ONCOLOGY. 350136 20540 THE FOUNDATION'S MOVE4HER PROGRAM CONSISTS OF A MONTH OF MOVEMENT TO RAISE FUNDS, INCREASE AWARENESS AND DRIVE EARLY DIANOSIS OF THE 5 GYN CANCERS. 411115 THE FOUNDATION'S SURVIVOR COURSES PROVIDE SUPPORT TO WOMEN AS THEIR GYNECOLOGIC CANCER JOURNEY CONTINUES. THESE COURSES PROVIDE THE MOST CURRENT INFORMATION ABOUT TREATMENT OPTIONS, RESEARCH AND QUALITY OF LIFE STRATEGIES TAUGHT BY LEADING EXPERTS, MOST GYNECOLOGIC ONCOLOGISTS. MOST COURSES FOCUS ON SPECIFIC GYNECOLOGIC CANCER - CERVICAL CANCER, OVARIAN CANCER, OR UTERINE CANCER. 1708766 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 16 16 0 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 IL X KELSE BARTLETT 3122354060 620 N LA SALLE DR CHICAGO IL 60654 PIERRE DESY CEO 15.00 25.00 X 0 264397 32035 HOLLY GIBOUT CHIEF DEVELOPMENT OFFICER FWC 40.00 1.00 X 0 205526 11231 TERI JORDAN CHIEF INDUSTRY RELATIONS & BDO 15.00 25.00 X 0 193929 15448 KAYLA WESTMAN CHIEF OF MEETINGS AND PROF 40.00 1.00 X 0 171058 10902 ELIZABETH KIX CHIEF MARKETING & COMM OFFICER 20.00 20.00 X 0 167362 13158 VEDA JACKSON CONTROLLER 20.00 20.00 X 0 147921 19505 TIM JOHNSTONE INTERIM CEO 15.00 25.00 X 0 88000 0 GINGER GARDNER MD CHAIRMAN 1.00 1.00 X X 0 0 0 LINDA DUSKA MD SECRETARY-TREASURER 1.00 1.00 X X 0 0 0 DAVID MUTCH MD PAST CHAIRMAN 1.00 X X 0 0 0 ERIN MEDLIN MD COMMUNICATIONS CHAIR 1.00 X 0 0 0 CHARLES LANDEN MD RESEARCH CHAIR 1.00 X 0 0 0 SHANNON ARMBRUSTER MD PATIENT EDUCATION CHAIR 1.00 X 0 0 0 JAMIE BAKKUM-GAMEZ MD DEVELOPMENT COMMITTEE CHAIR 1.00 X 0 0 0 STEPHANIE BLANK MD NOMINATING COMMITTEE CHAIR 1.00 1.00 X 0 0 0 ANGELES ALVAREZ-SECORD MD SGO PRESIDENT 1.00 1.00 X 0 0 0 WENDY BREWSTER MD PHD HONORS AND AWARDS CHAIR 1.00 X 0 0 0 AMANDA NICKLES FADER MD HONORS AND AWARDS CHAIR 1.00 1.00 X 0 0 0 ELOISE CHAPMAN-DAVIS DIHE REP 1.00 X 0 0 0 MONICA JONES MD BOARD MEMBER 1.00 X 0 0 0 WENDEL NAUMANN MD BOARD MEMBER 1.00 X 0 0 0 SUSAN MODESITT MD BOARD MEMBER 1.00 X 0 0 0 MATTHEW POWELL BOARD MEMBER 1.00 X 0 0 0 NAVYA NAIR MD DIHE VICE CHAIR (EX-OFFICIO) - TERM 1.00 X 0 0 0 CHAD HAMILTON MD BOARD MEMBER - TERM 1.00 X 0 0 0 0 1238193 102279 0 0 1 0 0 1903051 1903051 RACE REGISTRATION FEES 900099 20540 20540 20540 149032 149032 405923 0 405923 405923 405923 MISCELLANEOUS REVENUE 900099 28058 28058 28058 2506604 20540 0 583013 X 610000 610000 709523 591439 94029 24055 12155 12155 31544 31544 18997 18997 282028 260746 21282 61408 59914 1006 488 34454 15211 18525 718 34249 10299 12011 11939 36548 19805 583 16160 205974 141352 48483 16139 13050 13050 2049930 1708766 271665 69499 2176572 1996791 173000 201416 5678 5009 68446 68446 13050 0 4352675 5141442 6720975 7344658 878120 990249 294758 166106 1172878 1156355 X 3143620 3421301 2404477 2767002 5548097 6188303 6720975 7344658 456674 18532 165000 0 X 0 1 X 1 0 X 1441959 1541044 2143622 2328546 1903051 9358222 1441959 1541044 2143622 2328546 1903051 9358222 1556897 7801325 50827 115854 146925 87918 149032 550556 3433 1885 28058 33376 9942154 209135 0.78470 0.82140 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2557645 352409 2910054 3195030 -637385 2557645 2776344 418686 3195030 2232991 543353 2776344 1891407 77214 264370 2232991 0.82800 0.17200 0 0 68446 68446 0 0 DUE TO RELATED PARTY 166106 166106 X PART V, LINE 4: THE ENDOWMENT FUND WAS ESTABLISHED TO PROVIDE FUNDING FOR THE FOUNDATION'S RESEARCH AND EDUCATION ACTIVITIES. PART X, LINE 2: THE FOUNDATION IS A TAX-EXEMPT ORGANIZATION AS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (THE CODE) AND IS EXEMPT FROM FEDERAL INCOME TAXES ON RELATED UNCOME PURSUANT TO SECTION 501(A) OF THE CODE. IN ADDITION, THE INTERNAL REVENUE SERVICE (IRS) HAS DETERMINED THAT THE FOUNDATION IS NOT A PRIVATE FOUNDATION WITHIN THE MEANING OF SECTION 509(A) OF THE CODE. THE FOUNDATION DID NOT HAVE ANY UNRELATED BUSINESS INCOME DURING 2023. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION WAS NOT REQUIRED TO RECORD A LIABILITY RELATED TO UNCERTAIN TAX POSITIONS AT DECEMBER 31, 2023. 1 MD ANDERSON CANCER CENTER PO BOX 4266 HOUSTON TX 72210 746001118 501(C)(3) 100000 0 TO PROMOTE CANCER RESEARCH DREXEL UNIVERSITY COLLEGE OF MEDICINE HEALTH SCIENCES BUILDING 60 N 36TH STREET PHILADELPHIA PA 19104 231352630 501(C)(3) 50000 0 TO PROMOTE CANCER RESEARCH WASHINGTON UNIVERSITY IN SAINT LOUIS SCHOOL OF MEDICINE CAMPUS BOX 1082 ONE BOOKINGS DRIVE ST LOUIS MO 63130 430653611 501(C)(3) 50000 0 TO PROMOTE CANCER RESEARCH UNC LINEBERGER COMPREHENSIVE CANCER CENTER 450 WEST DR CHAPEL HILL NC 27599 566057494 501(C)(3) 100000 0 TO PROMOTE CANCER RESEARCH MEMORIAL SLOAN KETTERING 1275 YORK AVENUE NEW YORK NY 10065 131924236 501(C)(3) 75000 0 TO PROMOTE CANCER RESEARCH GEORGE WASHINGTON UNIVERSITY 1918 F STREET WASHINGTON DC 20052 530196584 501(C)(3) 50000 0 TO PROMOTE CANCER RESEARCH UNIVERSITY OF IOWA 375 NEWTON RD IOWA CITY IA 52242 426004813 501(C)(3) 25000 0 TO PROMOTE CANCER RESEARCH BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA MS BCM160 HOUSTON TX 77030 741613878 501(C)(3) 50000 0 TO PROMOTE CANCER RESEARCH EMORY UNIVERSITY 100 WOODRUFF CIRCLE ATLANTA GA 30322 580566256 501(C)(3) 50000 0 TO PROMOTE CANCER RESEARCH TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3819 CHESTNUT STREET SUITE 214 PHILADELPHIA PA 19104 231352685 501(C)(3) 50000 0 TO PROMOTE CANCER RESEARCH 10 PART I, LINE 2: AMOUNTS PAID OUT BY THE FOUNDATION ARE RESEARCH AWARDS, NO GRANT MONITORING IS PERFORMED. 0 0 0 0 0 0 0 0 0 PIERRE DESY CEO 0 253431 0 10966 0 0 0 15138 0 16897 0 296432 0 0 HOLLY GIBOUT CHIEF DEVELOPMENT OFFICER FWC 0 196776 0 8750 0 0 0 0 0 11231 0 216757 0 0 TERI JORDAN CHIEF INDUSTRY RELATIONS & BDO 0 187329 0 6600 0 0 0 9657 0 5791 0 209377 0 0 KAYLA WESTMAN CHIEF OF MEETINGS AND PROF 0 164658 0 6400 0 0 0 0 0 10902 0 181960 0 0 ELIZABETH KIX CHIEF MARKETING & COMM OFFICER 0 162862 0 4500 0 0 0 2539 0 10619 0 180520 0 0 VEDA JACKSON CONTROLLER 0 143508 0 4413 0 0 0 9235 0 10270 0 167426 0 0 PART I, LINE 3 ALL EMPLOYEES ARE PAID THROUGH THE SOCIETY OF GYNECOLOGIC ONCOLOGY (SGO), A RELATED ORGANIZATION. METHODS USED BY SGO TO ESTABLISH COMPENSATION FOR THE CEO INCLUDE THE USE OF AN INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION A, LINE 7A PER THE BYLAWS, THE BOARD OF DIRECTORS SHALL BE APPOINTED BY THE BOARD OF DIRECTORS OF THE SOCIETY OF GYNECOLGIC ONCOLOGY, A RELATED ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B THE CEO AND CONTROLLER REVIEW THE TAX RETURN BEFORE IT IS FILED. A COPY OF THE 990 IS PROVIDED TO ALL BOARD MEMBERS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THIS POLICY IS REVIEWED ANNUALLY WITH THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 15 THE CEO OF THE FOUNDATION IS COMPENSATED BY SGO, A RELATED ORGANIZATION. AS PART OF SGO'S PROCEDURES, COMPENSATION STUDIES WERE UTILIZED FOR THE STAFF AND CEO AND SALARIES WERE ADJUSTED ACCORDINGLY. ALL SALARIES ARE EVALUATED BY THE BOARD OF DIRECTORS ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING FEES: PROGRAM SERVICE EXPENSES 260,746. MANAGEMENT AND GENERAL EXPENSES 21,282. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 282,028. SOCIETY FOR GYNECOLOGIC ONCOLOGY 230 W MONROE ST SUITE 710 CHICAGO IL 60606 611657046 PROMOTE THE HIGHEST QUALITY OF CLINICAL CARE THROUGH EDUCATION AND RESEARCH IL 501(C)(6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 SOCIETY OF GYNECOLOGIC ONCOLOGY R 709523 BOOK VALUE